Documents

Files(12)

Name Size/Type Description Date
Dabrafenib & Trametinib consent 114KB PDF Dabrafenib & Trametinib consent 05 Oct 2020
Dacarbazine for melanoma consent 146KB PDF Dacarbazine for melanoma consent 16 May 2021
Dactinomycin consent 111KB PDF Dactinomycin consent 04 May 2021
Denosumab consent 111KB PDF Denosumab consent 12 Nov 2020
Docetaxel & Carboplatin consent 114KB PDF Docetaxel & Carboplatin consent 09 Jul 2020
Docetaxel & Cyclophosphamide consent 113KB PDF Docetaxel & Cyclophosphamide consent 21 Apr 2020
Docetaxel & Nintedanib consent 114KB PDF Docetaxel & Nintedanib consent 21 Apr 2020
Docetaxel consent 113KB PDF Docetaxel consent 21 Apr 2020
Docetaxel, Pertuzumab & Trastuzumab (MBC) consent 116KB PDF docetaxel pertuzumab trastuzumab consent 26 Feb 2021
Dostarlimab consent 113KB PDF Dostarlimab consent 29 Jul 2022
Doxorubicin consent 113KB PDF Doxorubicin consent 21 Apr 2020
Durvalumab consent 86KB PDF Durvalumab consent 30 Jan 2025

Chemotherapy Consent Forms for Solid Tumours

All consent forms on this website are for the use of St Luke’s Cancer Alliance staff in respect of St Luke’s Cancer Alliance patients only.
For those who do not work within St Luke’s Cancer Alliance:
Use of this site and any information on it is at your own risk. We do not accept responsibility for the use of any information that may be set out on the website. You assume full responsibility for the use of the information.  You may wish to take your own legal advice before using any of the consent forms.

Please note that the consent forms below are not tumour-specific; one consent form may be used to consent patients for more than one St Luke’s Alliance chemotherapy protocol which uses the same combination of chemotherapy.

These consent forms should act as an aide-memoire to health professionals and patients, by providing a check-list of the kind of information which patients should be offered, and by enabling the patient to have a written record of the main points discussed.

The relevant Macmillan leaflet(s) should also be provided to each patient before consent. In no way should written information given to the patient be regarded as a substitute for face-to-face discussions with the patient.

These consent forms are for solid tumour chemotherapy only, and are NOT to be used for chemo-radiotherapy regimens.